Purchase Order 75N93019P00552
Award Date 5/23/19
Potential Completion Date 5/22/20
Potential Value $100K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Chicago, IL 60607, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm-fixed price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Igenbio Inc., a minority-owned, self-certified small disadvantaged business, for an annual database license renewal. The contract has a ceiling value of $99,750.00 and an ultimate completion date of April 28, 2017. The contract does not have a set-aside designation. This contract award is for the provision of a database license and is not associated with a larger...
- <p>The National Institute of Allergy and Infectious Diseases (NIAID), a civilian federal agency, awarded a 1-year firm fixed price purchase order contract worth $99,750.00 to Igenbio Inc., a minority-owned small disadvantaged business, for a license renewal for the ERGO database. The contract does not have a set-aside designation. The award has an ultimate completion date of May 22, 2019.</p>
- This is a firm fixed price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services (HHS), to Igenbio Inc. for genomic sequencing services. The contract has a ceiling value of $5,600.00 and was awarded on November 20, 2015, with a final completion date of December 11, 2015. The contract was not set aside for any specific business type. Igenbio Inc. is a minority-owned, self-certified...
- The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, awarded a $49,946.10 firm-fixed-price purchase order contract for antibody expression services to Biointron Biological USA Inc., a small disadvantaged business. The contract, which has no set-aside designation, has an ultimate completion date of July 11, 2025. The award was made on July 12, 2024. NIAID is responsible for conducting and supporting research to understand, treat, and prevent infectious and...
- This is a one-year license renewal for the ERGO database, awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Igenbio Inc., a minority-owned, small disadvantaged business. The firm-fixed-price purchase order has a ceiling value of $99,750.00 and was awarded on April 22, 2015, with a completion date of April 28, 2016. The contract does not have a set-aside designation. Igenbio Inc. is the prime contractor, and no subcontractor information is...
- This federal contract award, HHSN272201400038P, was issued by the National Institute of Allergy and Infectious Diseases (NIAID) of the U.S. Department of Health and Human Services (HHS) to Igenbio Inc., a minority-owned small disadvantaged business. The $5,000.00 firm fixed-price purchase order is for other functions related to GenBank data preparation, including the addition of locus tags, upload, and GenBank submission. The contract has no set-aside designation and has a completion date of...
- This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to Geneimmune Biotechnology Corp, a small, Asian-Pacific American-owned biotechnology company based in Rockville, Maryland. The contract, valued at $98,958.95, is for the provision of various research and development services related to genetics, immunology, virology, and infectious diseases, including...
- <p>This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Integrated Genomics, Inc. The contract, valued at $9,950.00, is for the custom gene aliasing of Borrelia genomes. The contract has no set-aside designation and the period of performance ends on July 7, 2010. This contract appears to be related to NIAID's research activities, which include studying infectious diseases such as those caused by Borrelia bacteria.</p>
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $43,587.50 firm fixed price purchase order to Qiagen, LLC for one catalog item #834083, HGMD Data Download for clinical use by a medium-sized enterprise. The place of performance will be Qiagen's Germantown, Maryland division. The period of performance is January 1, 2024 through November 25, 2024. No set aside designation or subcontractors were indicated....
- This is a one-year license renewal for an ERGO database awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services (HHS). The $99,750.00 firm fixed-price purchase order was awarded on April 24, 2014 to Igenbio Inc., a minority-owned, self-certified small disadvantaged business. The contract did not have a set-aside designation, and the ultimate completion date was April 28, 2015. Igenbio Inc. is an...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $99,750.00 firm fixed price purchase order to Igenbio Inc., a minority-owned small disadvantaged business, for a 1-year service agreement to renew a genome analysis suite license. This contract has no set-aside designation. The contract supports NIAID's mission to conduct research to understand, treat, and prevent infectious diseases.
Generated 4/3/25, 12:36 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $99.8k | 5/14/19 |